Td Private Client Wealth LLC Nektar Therapeutics Transaction History

Td Private Client Wealth LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 16, 2024	SELL	$3.17 - $6.17 $640 - $1,246	-202 Closed	0 $0
Q1 2022 Aug 16, 2024	BUY	$4.16 - $13.72 $840 - $2,771	202 New	202 $1.09 Million
Q1 2021 Aug 16, 2024	SELL	$16.56 - $25.46 $132 - $203	-8 Closed	0 $0
Q3 2020 Aug 16, 2024	SELL	$16.59 - $24.79 $331 - $495	-20 Reduced 71.43%	8 $133,000
Q2 2020 Aug 16, 2024	SELL	$16.86 - $23.44 $741 - $1,031	-44 Reduced 61.11%	28 $648,000
Q1 2020 Aug 16, 2024	SELL	$14.47 - $27.96 $3,024 - $5,843	-209 Reduced 74.38%	72 $1.29 Million
Q4 2019 Aug 16, 2024	BUY	$15.87 - $23.12 $4,459 - $6,496	281 New	281 $6.07 Million

146

139M

32.6K

14.1K

Ticker NKTR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 187,404,992
Market Cap $189M
Description
Nektar Therapeutics, a biopharmaceutical company, focuses on discovering and developing medicines in areas of unmet medical need in the United States and internationally. The company's products include Bempegaldesleukin, a CD122-preferential interleukin-2 (IL-2) pathway agonist, which is in phase 3 clinical trial to treat metastatic melanoma, re...

Get notified when there are updates to the investment portfolio of Td Private Client Wealth LLC, based on Form 13F filings with the SEC.

Stay updated on Td Private Client Wealth LLC with notifications on news.